These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25264635)

  • 21. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
    Liu TT; Li XF; Wang L; Yang JL
    Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US.
    LaTrenta LR; Menell JH; Morris EA; Abramson AF; Dershaw DD; Liberman L
    Radiology; 2003 Jun; 227(3):856-61. PubMed ID: 12773685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
    Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
    Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do breast columnar cell lesions with atypia need to be excised?
    Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K
    Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast MRI: opportunities and challenges.
    Day D
    Minn Med; 2009 Dec; 92(12):45-8. PubMed ID: 20092173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Initial Imaging Modality Affect Breast Biopsy Upgrade Rates? A Single Institution Review.
    Scott RB; Dolkar T; Vidhun R; Osler T; Staradub VL
    Conn Med; 2016; 80(6):335-40. PubMed ID: 27509639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Features of non-mass enhancing lesions detected on 1.5 T breast MRI: a radiologic and pathologic analysis.
    Choudhery S; Lynch B; Sahoo S; Seiler SJ
    Breast Dis; 2015; 35(1):13-7. PubMed ID: 25061022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
    Mahoney MC; Robinson-Smith TM; Shaughnessy EA
    AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?].
    Teifke A; Vomweg TW; Hlawatsch A; Nasresfahani A; Kern A; Victor A; Schmidt M; Bittinger F; Düber C
    Rofo; 2006 Mar; 178(3):330-6. PubMed ID: 16508842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lobular neoplasia on core-needle biopsy--clinical significance.
    Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
    Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors that impact the upgrading of atypical ductal hyperplasia.
    Gümüş H; Mills P; Gümüş M; Fish D; Jones S; Jones P; Devalia H; Sever A
    Diagn Interv Radiol; 2013; 19(2):91-6. PubMed ID: 23019055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of breast cancer: factors affecting the accuracy of preoperative lesion sizing.
    Mennella S; Garlaschi A; Paparo F; Perillo M; Celenza M; Massa T; Rollandi GA; Garlaschi G
    Acta Radiol; 2015 Mar; 56(3):260-8. PubMed ID: 24526754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Breast lesion diagnosis: integrating pathology and radiology].
    Zonderland HM; van de Vijver MJ; Visser M
    Ned Tijdschr Geneeskd; 2011; 155(18):A2967. PubMed ID: 21466724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast magnetic resonance imaging for preoperative locoregional staging.
    Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE
    Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.